Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Latest round
Venture round
Oct 2026 · this month
Team
201-500
employees, estimated range
Backers
1
Aisling Capital
The money's age
Fresh money
0 months since the last round · not hiring
Momentum
20/100
fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Oct 2
Raised a round Venture round
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Oct 2026 | — | — | find-and-update.company-information.service.gov.uk |
Registers and programsofficial lists and records that name the company
| Legal entity | GSK plc | its site |
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers

Epigenic Therapeutics is a frontier biotechnology company dedicated to developing next generation gene modulation therapy utilizing…

Discover P95 full-service CRO clinical trial solutions. Experts in epidemiology and real-world evidence for vaccines and infectious…

Pantherna Therapeutics is a privately-held biopharmaceutical Company developing first-in-class therapeutics for vascular diseases…

True product innovation is a team-driven process that combines sound science with extensive, practical industry knowledge. To make a real…

Resilience360TM is the first enterprise software designed to future proof 1 billion assets and people ahead of disaster by 2030.

Immunogenicity intelligence, grounded in human biology.. — Problem.
News
GlaxoSmithKline and Stiefel to create new world-leading specialist dermatology business
Stiefel, the world
Read more
Report
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
London
United Kingdom
HQ
Codes, standards and reports
200-500 est. staff
Registered office: 79 New Oxford Street, London. United Kingdom. WC1A 1DG
Financials
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2026 | — | Details |

Aisling Capital 



